この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
ビジネス · 2018/5/31 分で読めます
Assessing User Fees Under the Prescription Drug User Fee Amendments of 2017; Guidance for Industry; Availability
ローカル自動翻訳 · 情報源の原言語
概要
The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance for industry entitled "Assessing User Fees Under the Prescription Drug User Fee Amendments of 2017." This guidance concerns FDA's implementation of the Prescription Drug User Fee Amendments of 2017 (PDUFA VI) and certain changes in policies and procedures surrounding its application.
情報源の原言語: Federal Register — Food and Drug Administration原文の発表を開く →